The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Claire - Canada: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Claire from Canada shares their Multiple Sclerosis (MS) and Low Dose Naltrexone (LDN) Story on the LDN Radio Show with Linda Elsegood.
Cindy was diagnosed when she was around 26 years old. She had never had any tummy problems or any symptoms prior to woking up one day and the restroom and there was blood in her stool.
Ciara - Scotland: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Ciara from Scotland shares her LDN story she has primary progressive.
Christine - US: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood: This evening. We're joined by Christine from the United States who takes LDN for multiple sclerosis. Thank you for joining us, Christine.
Christine: Thank you for having me.
Christian, from Germany, takes low dose naltrexone (LDN) for multiple sclerosis (MS). He was diagnosed at age 30, in 2001.
I am Chris from Taiwan and I have Sjogren's Syndrome.
Linda: I’d like to introduce Chris from Scotland, who has primary progressive MS. Welcome, Chris. Can you tell us when you first started noticing your MS symptoms?
Chris - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood: I'd like to welcome Chris from England and Chris has multiple sclerosis. Welcome Chris
Chris: Good evening.
Linda Elsegood: Could you tell us your story?
Cheryl - US: Lyme Disease (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Cheryl from the United States takes LDN for Lyme disease and Co infections.
Her story goes back into childhood. She had always struggled with some sort of illnesses. Gastrointestinal issues, stomach virus, rashes on her face, etc
Celia - Ireland: Parkinson's (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Celia from Ireland takes Low Dose Naltrexone (LDN) for Parkinson's disease.
Summary